The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome
- PMID: 16337726
- DOI: 10.1016/j.ejogrb.2005.11.012
The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome
Abstract
Objective: The aim of the study was to compare the body fat distribution of women with polycystic ovary syndrome (PCOS) with age and body mass index matched healthy controls and to investigate if androgens and insulin resistance associated with fat distribution.
Study design: Thirty-three PCOS and 21 age and body mass index (BMI) matched healthy control women were evaluated in terms of body fat distribution with dual X-ray absorpsiometry (DEXA). Blood samples were obtained for follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol, prolactin, thyroid stimulating hormone (TSH), dehydroepiandrosterone-sulfate (DHEA-S), free testosterone, sex hormone binding globulin (SHBG), insulin and glucose levels. A 75 g 2 h glucose tolerance test was performed for each woman. Insulin resistance was estimated by fasting insulin level, fasting glucose/insulin ratio and 75 g 2 h glucose tolerance test. The Student's t-test and Mann-Whitney U-test were used to compare the groups. Pearson and Spearman rank correlation coefficients were calculated for normally and nonnormally distributed variables, respectively. Partial correlation coefficients were calculated using age and BMI as covariates.
Results: Fat mass in trunk and arms were significantly higher in patients with PCOS (p < 0.043 and 0.036, respectively). The ratio of fat mass in trunk to fat mass in legs were significantly higher in patients with PCOS (p < 0.011). Free testosterone was found to be positively correlated with fat mass in arms (r = 0.401, p < 0.05). There was still significant correlation between free testosterone and fat mass in arms (r = 0.5964, p < 0.05) after controlling for age and BMI.
Conclusion: Free testosterone level is positively correlated with the fat mass in arms in women with PCOS.
Similar articles
-
Body fat composition and distribution in women with polycystic ovary syndrome.Gynecol Endocrinol. 2008 Aug;24(8):428-32. doi: 10.1080/09513590802234253. Gynecol Endocrinol. 2008. PMID: 18850379
-
Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.Eur J Obstet Gynecol Reprod Biol. 2014 Sep;180:56-60. doi: 10.1016/j.ejogrb.2014.06.004. Epub 2014 Jun 13. Eur J Obstet Gynecol Reprod Biol. 2014. PMID: 25020276
-
The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.Clin Endocrinol (Oxf). 1994 Oct;41(4):473-81. doi: 10.1111/j.1365-2265.1994.tb02578.x. Clin Endocrinol (Oxf). 1994. PMID: 7955458
-
A systematic review of GLP-1 agonists on the metabolic syndrome in women with polycystic ovaries.Arch Gynecol Obstet. 2016 Mar;293(3):509-15. doi: 10.1007/s00404-015-3976-7. Epub 2015 Dec 10. Arch Gynecol Obstet. 2016. PMID: 26660657 Review.
-
The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis.Obes Rev. 2013 Feb;14(2):95-109. doi: 10.1111/j.1467-789X.2012.01053.x. Epub 2012 Oct 31. Obes Rev. 2013. PMID: 23114091 Review.
Cited by
-
The Role of Different Methods in Defining Cardiometabolic Risk and Metabolic Syndrome in Women with Polycystic Ovary Syndrome.Life (Basel). 2023 Sep 25;13(10):1959. doi: 10.3390/life13101959. Life (Basel). 2023. PMID: 37895341 Free PMC article.
-
Visceral adiposity index and lipid accumulation product index: The promising role in assessing cardiometabolic risk in non-obese patients of PCOS.J Educ Health Promot. 2023 May 31;12:148. doi: 10.4103/jehp.jehp_1605_22. eCollection 2023. J Educ Health Promot. 2023. PMID: 37404927 Free PMC article.
-
Body Composition and Its Impact on the Hormonal Disturbances in Women with Polycystic Ovary Syndrome.Nutrients. 2021 Nov 24;13(12):4217. doi: 10.3390/nu13124217. Nutrients. 2021. PMID: 34959767 Free PMC article.
-
Imaging-Based Body Fat Distribution in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.Front Endocrinol (Lausanne). 2021 Sep 9;12:697223. doi: 10.3389/fendo.2021.697223. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34566888 Free PMC article.
-
Body Composition, Serum Concentrations of Androgens and Insulin Resistance in Different Polycystic Ovary Syndrome Phenotypes.J Clin Med. 2020 Mar 9;9(3):732. doi: 10.3390/jcm9030732. J Clin Med. 2020. PMID: 32182752 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous